According to Credence Research, the global bioprocess technology market was valued at USD 55.63 billion in 2025 and is projected to reach USD 134.06 billion by 2035. The market is expected to grow at a compound annual growth rate of 9.19% over the 2025 to 2035 interval.
Market Segments and Regional Shares
Consumables and accessories represented 62.0% of product revenue in 2025, while downstream processing accounted for 54.0% of process revenue. Fed-batch technology represented 58.0% of technology revenue during the same year.
North America held the largest regional share at 40.0% in 2025. Meanwhile, Asia Pacific is expected to record the fastest growth with a modeled annual growth rate of 10.38%.
Industry Developments and Key Competitors
Thermo Fisher completed its approximately USD 4 billion acquisition of Solventum's purification and filtration business in September 2025. The FDA also finalized its Advanced Manufacturing Technologies Designation Program guidance in December 2024.
Key market players include Thermo Fisher Scientific, Danaher, Sartorius, and Merck KGaA. Competitors also include Eppendorf, Bio-Rad Laboratories, Agilent Technologies, Getinge, and Advanced Instruments.
Key facts and where they come from
- The global bioprocess technology market is projected to reach USD 134.06 billion by 2035.
Revenue is projected to reach USD 134.06 billion by 2035
- North America held the largest regional share at 40.0% in 2025.
North America held the largest regional share at 40.0% in 2025
- Thermo Fisher completed its acquisition of Solventum's purification and filtration business for approximately USD 4.0 billion in cash in September 2025.
Thermo Fisher completed its acquisition of Solventum's purification and filtration business for approximately USD 4.0 billion in cash.
Read the original from Company press releases (PR Newswire) →